Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis
The complex pathology of Alzheimer’s disease (AD) emphasises the need for comprehensive modelling of the disease, which may lead to the development of efficient treatment strategies. To address this challenge, we analysed transcriptome data of post-mortem human brain samples of healthy elders and in...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d63a20cc32b49bab93cf1a8655cf91a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9d63a20cc32b49bab93cf1a8655cf91a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9d63a20cc32b49bab93cf1a8655cf91a2021-11-11T17:02:26ZRevealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis10.3390/ijms2221115561422-00671661-6596https://doaj.org/article/9d63a20cc32b49bab93cf1a8655cf91a2021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11556https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The complex pathology of Alzheimer’s disease (AD) emphasises the need for comprehensive modelling of the disease, which may lead to the development of efficient treatment strategies. To address this challenge, we analysed transcriptome data of post-mortem human brain samples of healthy elders and individuals with late-onset AD from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP) and Mayo Clinic (MayoRNAseq) studies in the AMP-AD consortium. In this context, we conducted several bioinformatics and systems medicine analyses including the construction of AD-specific co-expression networks and genome-scale metabolic modelling of the brain in AD patients to identify key genes, metabolites and pathways involved in the progression of AD. We identified <i>AMIGO1</i> and <i>GRPRASP2</i> as examples of commonly altered marker genes in AD patients. Moreover, we found alterations in energy metabolism, represented by reduced oxidative phosphorylation and ATPase activity, as well as the depletion of hexanoyl-CoA, pentanoyl-CoA, (2E)-hexenoyl-CoA and numerous other unsaturated fatty acids in the brain. We also observed that neuroprotective metabolites (e.g., vitamins, retinoids and unsaturated fatty acids) tend to be depleted in the AD brain, while neurotoxic metabolites (e.g., β-alanine, bilirubin) were more abundant. In summary, we systematically revealed the key genes and pathways related to the progression of AD, gained insight into the crucial mechanisms of AD and identified some possible targets that could be used in the treatment of AD.Abdulahad BayraktarSimon LamOzlem AltayXiangyu LiMeng YuanCheng ZhangMuhammad ArifHasan TurkezMathias UhlénSaeed ShoaieAdil MardinogluMDPI AGarticleAlzheimer’s diseasegene co-expression networkgenome-scale metabolic modelreporter metabolite analysisenergy metabolismBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11556, p 11556 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alzheimer’s disease gene co-expression network genome-scale metabolic model reporter metabolite analysis energy metabolism Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
Alzheimer’s disease gene co-expression network genome-scale metabolic model reporter metabolite analysis energy metabolism Biology (General) QH301-705.5 Chemistry QD1-999 Abdulahad Bayraktar Simon Lam Ozlem Altay Xiangyu Li Meng Yuan Cheng Zhang Muhammad Arif Hasan Turkez Mathias Uhlén Saeed Shoaie Adil Mardinoglu Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
description |
The complex pathology of Alzheimer’s disease (AD) emphasises the need for comprehensive modelling of the disease, which may lead to the development of efficient treatment strategies. To address this challenge, we analysed transcriptome data of post-mortem human brain samples of healthy elders and individuals with late-onset AD from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP) and Mayo Clinic (MayoRNAseq) studies in the AMP-AD consortium. In this context, we conducted several bioinformatics and systems medicine analyses including the construction of AD-specific co-expression networks and genome-scale metabolic modelling of the brain in AD patients to identify key genes, metabolites and pathways involved in the progression of AD. We identified <i>AMIGO1</i> and <i>GRPRASP2</i> as examples of commonly altered marker genes in AD patients. Moreover, we found alterations in energy metabolism, represented by reduced oxidative phosphorylation and ATPase activity, as well as the depletion of hexanoyl-CoA, pentanoyl-CoA, (2E)-hexenoyl-CoA and numerous other unsaturated fatty acids in the brain. We also observed that neuroprotective metabolites (e.g., vitamins, retinoids and unsaturated fatty acids) tend to be depleted in the AD brain, while neurotoxic metabolites (e.g., β-alanine, bilirubin) were more abundant. In summary, we systematically revealed the key genes and pathways related to the progression of AD, gained insight into the crucial mechanisms of AD and identified some possible targets that could be used in the treatment of AD. |
format |
article |
author |
Abdulahad Bayraktar Simon Lam Ozlem Altay Xiangyu Li Meng Yuan Cheng Zhang Muhammad Arif Hasan Turkez Mathias Uhlén Saeed Shoaie Adil Mardinoglu |
author_facet |
Abdulahad Bayraktar Simon Lam Ozlem Altay Xiangyu Li Meng Yuan Cheng Zhang Muhammad Arif Hasan Turkez Mathias Uhlén Saeed Shoaie Adil Mardinoglu |
author_sort |
Abdulahad Bayraktar |
title |
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
title_short |
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
title_full |
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
title_fullStr |
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
title_full_unstemmed |
Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis |
title_sort |
revealing the molecular mechanisms of alzheimer’s disease based on network analysis |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/9d63a20cc32b49bab93cf1a8655cf91a |
work_keys_str_mv |
AT abdulahadbayraktar revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT simonlam revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT ozlemaltay revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT xiangyuli revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT mengyuan revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT chengzhang revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT muhammadarif revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT hasanturkez revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT mathiasuhlen revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT saeedshoaie revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis AT adilmardinoglu revealingthemolecularmechanismsofalzheimersdiseasebasedonnetworkanalysis |
_version_ |
1718432191811158016 |